Description

Pegmolesatide(HS-20039; EPO-018B) a synthetic peptide-based erythropoiesis-stimulating agent, can be used for ??the study of anemia in chronic kidney disease[1].—–(C2H4O)n(C2H4O)nC231H344N72O64S4—-[1]J. CHEN, et al. POS-606 Pegmolesatide for the treatment of anemia in CKD patients undergoing dialysis: Interim analysis of a multicenter phase Ⅲ trial. ABSTRACT, VOLUME 7, ISSUE 2, SUPPLEMENT , S260, FEBRUARY 2022–2420483-81-2–N/A—-[PEGn-Chain1:GGTYSCHFGALTWVCRPQRG-{Bal}-K-NH2 (Disulfide bridge:Cys6-Cys15) Chain2:GGTYSCHFGALTWVCRPQRG-{Bal}-K-NH2 (Disulfide bridge:Cys6-Cys15) Chain3:K-{Bal}-G (Amide bridge:Chain1 Lys22-Chain Gly3; Covalent bridge:Chain Lys22-Chain3 Gly3)]–Endocrinology–10 mM in DMSO–Others—-Others–Peptides